Peter David Davis

Person

Oxford, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Benzimidazole vascular damaging agents
- Patent number 7,875,727
- Issue date Jan 25, 2011
- Angiogene Pharmaceuticals Ltd.
- Peter D. Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted stilbene compounds with vascular damaging activity
- Patent number 7,265,136
- Issue date Sep 4, 2007
- Angiogene Pharmaceuticals Ltd.
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Colchinol derivatives as vascular damaging agents
- Patent number 7,135,502
- Issue date Nov 14, 2006
- Angiogene Pharmaceuticals Ltd.
- Peter D Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions with vascular damaging activity
- Patent number 7,105,501
- Issue date Sep 12, 2006
- Angiogene Pharmaceuticals Ltd.
- Peter David Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combinations for the treatment of diseases involving angiogenesis
- Patent number 7,087,627
- Issue date Aug 8, 2006
- Angiogene Pharmaceuticals Ltd.
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzimidazole vascular damaging agents
- Patent number 7,081,469
- Issue date Jul 25, 2006
- Angiogene Pharmaceuticals Ltd.
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosi...
- Patent number 7,012,076
- Issue date Mar 14, 2006
- Celltech R & D Limited
- David Festus Charles Moffat
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-acetylcolchinol-O-phosphate combination therapies with vascular d...
- Patent number 6,906,048
- Issue date Jun 14, 2005
- Astrazeneca AB
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzimidazole vascular damaging agents
- Patent number 6,645,950
- Issue date Nov 11, 2003
- Angiogene Pharmaceuticals Ltd.
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused polycyclic 2-aminopyrimidine derivatives
- Patent number 6,599,908
- Issue date Jul 29, 2003
- Celltech R&D Limited
- Jeremy Martin Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-pyrimidineamine derivatives and processes for their preparation
- Patent number 6,552,029
- Issue date Apr 22, 2003
- Celltech R&D Limited
- Peter David Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
- Patent number 6,337,335
- Issue date Jan 8, 2002
- Celltech Therapeutics Limited
- Martin Clive Hutchings
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
- Patent number 6,235,746
- Issue date May 22, 2001
- Celltech Therapeutics, Limited
- Peter David Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused polycyclic 2-aminopyrimidine derivatives
- Patent number 6,133,257
- Issue date Oct 17, 2000
- Celltech Therapeutics Limited
- Mark James Batchelor
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-Pyrimidineamine derivatives and processes for their preparation
- Patent number 6,114,333
- Issue date Sep 5, 2000
- Celltech Therapeutics Ltd.
- Peter David Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 2-pyrimidineamines and processes for their preparation
- Patent number 6,093,716
- Issue date Jul 25, 2000
- Celltech Therapeutics, Limited
- Peter David Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused polycyclic 2-aminopyrimidine derivatives
- Patent number 6,057,329
- Issue date May 2, 2000
- Celltech Therapeutics Limited
- Jeremy Martin Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 2-anilinopryimidines useful as protein kinase inhibitors
- Patent number 6,048,866
- Issue date Apr 11, 2000
- Celltech Therapeutics, Limited
- Martin Clive Hutchings
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
- Patent number 5,958,935
- Issue date Sep 28, 1999
- Celltech Therapeutics Limited
- Peter David Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
5-aminopyrazoles useful as tyrosine kinase inhibitors
- Patent number 5,922,741
- Issue date Jul 13, 1999
- Celltech Therapeutics Ltd.
- Peter David Davis
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Method and Composition for Alleviating Tumor Symptoms
- Publication number 20150141349
- Publication date May 21, 2015
- Angiogene Pharmaceuticals Ltd.
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bioreductively-activated prodrugs
- Publication number 20090202571
- Publication date Aug 13, 2009
- Hopnic Laboratory Co., Ltd.
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bioreductively-Activated Prodrugs
- Publication number 20080145372
- Publication date Jun 19, 2008
- ANGIOGENE, PHARMACEUTICALS LIMITED
- Peter David Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bioreductively-activated prodrugs
- Publication number 20070099871
- Publication date May 3, 2007
- ANGIOGENE PHARMACEUTICALS LIMITED
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Divided dose therapies with vascular damaging activity
- Publication number 20070021392
- Publication date Jan 25, 2007
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Benzimidazole vascular damaging agents
- Publication number 20060264492
- Publication date Nov 23, 2006
- Angiogene Pharmaceuticals Ltd.
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bioreductively activated stilbene prodrugs
- Publication number 20060223827
- Publication date Oct 5, 2006
- Siemens Aktiengesellschaft
- Peter David Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combinations for the treatment of diseases involving angiogenesis
- Publication number 20060198846
- Publication date Sep 7, 2006
- Angiogene Pharmaceuticals Ltd.
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Colchinol derivatives as vascular damaging agents
- Publication number 20060128633
- Publication date Jun 15, 2006
- Angiogene Pharmaceuticals Ltd.
- Peter D. Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-acetylcolchinol-o-phosphate combination therapies with vascular d...
- Publication number 20050107346
- Publication date May 19, 2005
- AstraZeneca AB
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Benzimidazole vascular damaging agents
- Publication number 20040058972
- Publication date Mar 25, 2004
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions with vascular damaging activity
- Publication number 20030181424
- Publication date Sep 25, 2003
- Peter David Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination therapies with vascular damaging activity
- Publication number 20030166617
- Publication date Sep 4, 2003
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosi...
- Publication number 20030153755
- Publication date Aug 14, 2003
- David Festus Charles Moffat
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Divided dose therapies with vascular damaging activity
- Publication number 20030055024
- Publication date Mar 20, 2003
- Peter David Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Peter David Davis

Person

Patents Grantslast 30 patents

Benzimidazole vascular damaging agents

Substituted stilbene compounds with vascular damaging activity

Colchinol derivatives as vascular damaging agents

Compositions with vascular damaging activity

Combinations for the treatment of diseases involving angiogenesis

Benzimidazole vascular damaging agents

Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosi...

N-acetylcolchinol-O-phosphate combination therapies with vascular d...

Benzimidazole vascular damaging agents

Fused polycyclic 2-aminopyrimidine derivatives

2-pyrimidineamine derivatives and processes for their preparation

Substituted 2-anilinopyrimidines useful as protein kinase inhibitors

Substituted 2-anilinopyrimidines useful as protein kinase inhibitors

Fused polycyclic 2-aminopyrimidine derivatives

2-Pyrimidineamine derivatives and processes for their preparation

Substituted 2-pyrimidineamines and processes for their preparation

Fused polycyclic 2-aminopyrimidine derivatives

Substituted 2-anilinopryimidines useful as protein kinase inhibitors

Substituted 2-anilinopyrimidines useful as protein kinase inhibitors

5-aminopyrazoles useful as tyrosine kinase inhibitors

Patents Applicationslast 30 patents

Method and Composition for Alleviating Tumor Symptoms

Bioreductively-activated prodrugs

Bioreductively-Activated Prodrugs

Bioreductively-activated prodrugs

Divided dose therapies with vascular damaging activity

Benzimidazole vascular damaging agents

Bioreductively activated stilbene prodrugs

Combinations for the treatment of diseases involving angiogenesis

Colchinol derivatives as vascular damaging agents

N-acetylcolchinol-o-phosphate combination therapies with vascular d...

Benzimidazole vascular damaging agents

Compositions with vascular damaging activity

Combination therapies with vascular damaging activity

Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosi...

Divided dose therapies with vascular damaging activity